Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aurinia Pharm Ord
(NQ:
AUPH
)
5.680
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharm Ord
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
62 Biggest Movers From Yesterday
July 29, 2021
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Understanding Aurinia Pharmaceuticals's Unusual Options Activity
July 28, 2021
On Wednesday, shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) saw unusual options activity. After the option alert, the stock price moved up to $12.55. Sentiment: BULLISH Option...
Via
Benzinga
Banned Merger
July 27, 2021
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood.
Via
Talk Markets
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021
July 26, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
July 16, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs
June 30, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
June 25, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
The First Day Of Summer And Prime Day
June 21, 2021
The bull is back in business today.
Via
Talk Markets
Two Rate Hikes In 2023
June 16, 2021
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
June 14, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Aurinia Announces Results of the 2021 Annual General Meeting
June 07, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
June 07, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
Unusual Options Activity Insight: Aurinia Pharmaceuticals
June 03, 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Thursday. The stock price moved down to $13.6 following the option alert. Sentiment: BEARISH...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
June 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients
May 21, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced a supportive interim analysis of its AURORA 2 continuation study evaluating Lupkynis (voclosporin) in...
Via
Benzinga
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis
May 20, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
May 19, 2021
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.
Via
The Motley Fool
Exposures
COVID-19
Another Tough Day For Markets
May 17, 2021
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”
Via
Talk Markets
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
May 14, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Heavy Global Erosion
May 11, 2021
It is an everything-down day. Even the news is down because commenters are being careful.
Via
Talk Markets
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis
May 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Exposures
COVID-19
Product Safety
Stocks That Hit 52-Week Lows On Monday
May 10, 2021
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....
Via
Benzinga
Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet
May 10, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced that The Lancet published its Phase 3 AURORA 1 study evaluating Lupkynis (voclosporin) in adults with...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.